Source link : https://www.newshealth.biz/health-news/rsv-vaccine-90-effective-in-high-risk-adults-real-world-study-shows/
The bivalent RSV prefusion F vaccine (Abrysvo) demonstrated 90% vaccine effectiveness (VE) in high-risk adults against hospitalizations or emergency department (ED) visits associated with respiratory syncytial virus (RSV), according to recent real-world data presented at the IDWeek annual meeting in Los Angeles. In this exclusive MedPage Today video, Sara Tartof, PhD, MPH, of Kaiser Permanente […]
Author : News Health
Publish date : 2024-10-30 18:10:40
Copyright for syndicated content belongs to the linked Source.